关于蒙特卢卡斯特药理潜力的新见解:全面审查
Karan Goel1, Dhirendra Singh1, Rajat Goyal2
1Department of Pharmacology, Maharishi Markandeshwar College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, 133207, India.
Inflammopharmacology
|July 27, 2025
概括
蒙特卢卡斯特是一种有效的白血素受体对抗剂,可治疗喘和花粉热. 它还显示出神经保护,癌症和心血管疾病的前景,因为它具有抗炎性质.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 胰岛素是通过胰岛素受体作用的脂质介质,影响各种生理和生化反应.
- 叶可氨酸路径与炎症状况有关,包括神经,心血管,代谢,脏,肝脏疾病和癌症.
- 抗胰岛素剂调节炎症反应,提供治疗潜力.
研究的目的:
- 重点关注蒙特卢卡斯特,审查抗白三烯剂的药理作用.
- 探索蒙特卢卡斯特除了呼吸道疾病之外的各种治疗应用.
- 突出Montelukast的作用机制及其在治疗炎症疾病中的作用.
主要方法:
- 关于leukotrienes和Montelukast的研究的文献综述.
- 分析蒙特卢卡斯特的药理活动和机制.
- 检查临床应用和新兴研究.
主要成果:
- 蒙特卢卡斯特是一种有效的口服活性白血素受体对手,已被批准用于喘和花粉热.
- 蒙特卢卡斯特具有显著的抗炎,抗癌,神经保护,心脏保护和其他保护作用.
- 它的机制涉及调节白血蛋白通路,影响各种疾病过程.
结论:
- 蒙特卢卡斯特是一种多功能的药物,在呼吸系统疾病中已被证实有效,在许多其他疾病中也有潜力.
- 它对抗白血受体的能力是其广泛的治疗益处的基础.
- 对蒙特卢卡斯特多方面的药理作用进行进一步研究是有必要的.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
453
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
453
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
446
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
446
Asthma: Pathogenesis and Management
573
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
573
Drugs Used in Lower Respiratory Disorders: Overview
573
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
573
Antiasthma Drugs: Methylxanthines
391
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
391
Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K


